Bayer proposes $10.25 billion plan for all Roundup cancer cases

BERLIN, Feb 17 (Reuters) - Bayer said on Tuesday that its Monsanto unit had filed a proposed U.S. class settlement ‌totalling as much as $7.25 billion that was aimed at ‌resolving current and future claims that its Roundup weedkiller caused Non‑Hodgkins lymphoma. The German company ​said the proposed nationwide settlement, filed in the Circuit Court of the City of St. Louis, Missouri, would establish a long‑term claims programme funded by capped annual payments over up to 21 years. Bayer, ‌which has be ...